Singapore
Jim Lim joins Zühlke Group as Head of Health & Medtech in Singapore
With over 24 years of ICT industry experience, Jim brings his wealth of experience providing strategic, business and technological advice to global clients...
April 21, 2023 | News
Veeva Systems Finds Digital Content More Effective Than In-Person Meetings in Biopharma Industry
Veeva Systems (NYSE: VEEV) today released the latest Veeva Pulse Field Trends Report, the largest analysis of global healthcare professiona...
April 20, 2023 | News
Hasten Biopharma has secured a US$315 million fundraising round led jointly by CBC Group and Mubadala
CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm headquartered in Singapore, and Hasten Biopharmaceutic Company Limite...
April 20, 2023 | News
Roquette Cuts Ribbon on $25 Million Pharmaceutical Innovation Center in the United States
Staffed with a team of highly skilled research, application and formulation experts, the new $25 million center will be an advanced training and coll...
April 20, 2023 | News
Biosyngen announces FDA IND approval of its second product for EBV-positive lymphoma
A few months earlier, the Company's first product (BRG01) targeting relapsed/metastatic nasopharyngeal cancer has been granted IND approval by both the US ...
April 19, 2023 | News
Scientists from Singapore and Sweden achieve promising results towards restoring vision in blindness caused by cellular degeneration in the eye
A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplanting th...
April 17, 2023 | News
Evonik wins Asia-Pacific Bioprocessing Excellence Award for Cell Culture Solutions
The Asia-Pacific Bioprocessing Excellence Awards celebrate the latest biopharmaceutical technologies Evonik recognized for high-quality Cell Culture Sol...
April 13, 2023 | News
FINN Partners & Galen Growth will Host Digital Health Investment Summit in Boston
Digital Health Funding in Massachusetts Continues to Thrive Led by Investment in Key Therapeutic Areas Galen Growth, the...
April 12, 2023 | News
Biosyngen received China NMPA IND approval for its T-cell redirection therapy targeting EBV-positive Lymphoma
Currently, commercially available cell therapies, such as CD19 CAR-T, are designed for the treatment of B cell lymphoma or acute lymphoblastic leukemia. Tr...
April 12, 2023 | News
Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics
The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...
April 12, 2023 | News
Airlangga University Hospital signs MOU with Singapore's Icon Cancer Center
As the first hospital in Indonesia to cooperate with Icon Cancer Center, Airlangga University Hospital is supporting the government's efforts to promote he...
April 10, 2023 | News
OrganaBio Delivers RUO & GMP LeukoPAC™ Collections to Singapore
The monoclonal antibodies (mAbs) daratumumab, and elotuzumab have been approved by the U.S. Food and Drug Administration for treating multiple myeloma (MM)...
April 10, 2023 | News
Tuberculosis patients see dramatic cut in treatment duration, treatment effectiveness remains
The TRUNCATE-TB trial recruited 675 people who were diagnosed with pulmonary TB and randomly allocated them to receive the standard treatment for six...
April 06, 2023 | Analysis
Singapore HSA Accepts Everest Medicines' Nefecon Application for IgA Nephropathy Treatment
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commerc...
April 06, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
